Literature DB >> 1357438

Combined oestrogen-progestogen replacement and breast cancer risk.

I Persson, J Yuen, L Bergkvist, H O Adami, R Hoover, C Schairer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357438     DOI: 10.1016/0140-6736(92)93064-t

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Hormone replacement therapy and breast cancer. A review of current knowledge.

Authors:  L Bergkvist; I Persson
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

2.  Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect.

Authors:  J Yuen; I Persson; L Bergkvist; R Hoover; C Schairer; H O Adami
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

Review 3.  The adverse effects of hormone replacement therapy.

Authors:  A Tavani; C La Vecchia
Journal:  Drugs Aging       Date:  1999-05       Impact factor: 3.923

Review 4.  Postmenopausal hormone replacement therapy: effects on normal mammary gland in humans and in a mouse postmenopausal model.

Authors:  Sandra Z Haslam; Janet R Osuch; A M Raafat; L J Hofseth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

Review 5.  Estrogen replacement therapy in survivors of breast cancer: a risk-benefit assessment.

Authors:  J A Eden
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

Review 6.  Breast cancer prevention through modulation of endogenous hormones.

Authors:  D V Spicer; M C Pike
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

7.  Estrogen-progestin replacement therapy: regulatory action needed.

Authors:  Malcolm C Pike; Ronald K Ross
Journal:  Breast Cancer Res       Date:  2002-10-08       Impact factor: 6.466

8.  Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease.

Authors:  G Plu-Bureau; M G Lê; R Sitruk-Ware; J C Thalabard; P Mauvais-Jarvis
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.